Author: super@dmin

John J. Ray III is set to lay out an alarming picture to Congress of how badly mismanaged the crypto exchange really was.

Amgen Inc. is acquiring Dublin-based Horizon Therapeutics in a roughly $28 billion deal that is the biggest in the healthcare sector in 2022.

The so-called Index Effect — a stock’s rise or fall when it’s added or deleted from an index — no longer exists.

Consumers will be more likely to seek out cheaper alternatives for jeans than for handbags in what is likely to be a ‘choppy’ year, Goldman analysts say.

FTX founder Sam Bankman-Fried will testify to a House panel on Tuesday remotely instead of in person.

A struggling U.S. stock market will next year have to contend with relatively attractive European equities after a recent shift toward value stocks, according to RBC Capital Markets.

Leaders can guide their organization through uncharted territory with ‘deliberate calm.’

Economic weakness plus tighter monetary policy should push inflation below expectations next year, said DoubleLine Capital’s Jeffrey Gundlach.

Nvidia’s stock has had a rough year, shedding more than 40% so far in 2022, but one analyst thinks now is the time for investors to get on board.

Mark Fischer of Royce Investment Partners outlines his approach for selecting stocks that are underfollowed by analysts.